Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15701627rdf:typepubmed:Citationlld:pubmed
pubmed-article:15701627lifeskim:mentionsumls-concept:C0012854lld:lifeskim
pubmed-article:15701627lifeskim:mentionsumls-concept:C0332157lld:lifeskim
pubmed-article:15701627lifeskim:mentionsumls-concept:C1155873lld:lifeskim
pubmed-article:15701627lifeskim:mentionsumls-concept:C0086982lld:lifeskim
pubmed-article:15701627lifeskim:mentionsumls-concept:C2257266lld:lifeskim
pubmed-article:15701627lifeskim:mentionsumls-concept:C2917430lld:lifeskim
pubmed-article:15701627lifeskim:mentionsumls-concept:C1292733lld:lifeskim
pubmed-article:15701627pubmed:issue16lld:pubmed
pubmed-article:15701627pubmed:dateCreated2005-4-19lld:pubmed
pubmed-article:15701627pubmed:abstractTextMouse fibroblasts, deficient in DNA polymerase beta, are hypersensitive to monofunctional DNA methylating agents such as methyl methanesulfonate (MMS). Both wild-type and, in particular, repair-deficient DNA polymerase beta null cells are highly sensitized to the cytotoxic effects of MMS by 4-amino-1,8-naphthalimide (4-AN), an inhibitor of poly(ADP-ribose) polymerase (PARP) activity. Experiments with synchronized cells suggest that exposure during S-phase of the cell cycle is required for the 4-AN effect. 4-AN elicits a similar extreme sensitization to the thymidine analog, 5-hydroxymethyl-2'-deoxyuridine, implicating the requirement for an intermediate of DNA repair. In PARP-1-expressing fibroblasts treated with a combination of MMS and 4-AN, a complete inhibition of DNA synthesis is apparent after 4 h, and by 24 h, all cells are arrested in S-phase of the cell cycle. Continuous incubation with 4-AN is required to maintain the cell cycle arrest. Caffeine, an inhibitor of the upstream checkpoint kinases ATM (ataxia telangiectasia-mutated) and ATR (ATM and Rad3-related), has no effect on the early inhibition of DNA synthesis, but cells are no longer able to maintain the block after 8 h. Instead, the addition of caffeine leads to arrest of cells in G(2)/M rather than S-phase after 24 h. Analysis of signaling pathways in cell extracts reveals an activation of Chk1 after treatment with MMS and 4-AN, which can be suppressed by caffeine. Our results suggest that inhibition of PARP activity results in sensitization to MMS through maintenance of an ATR and Chk1-dependent S-phase checkpoint.lld:pubmed
pubmed-article:15701627pubmed:languageenglld:pubmed
pubmed-article:15701627pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15701627pubmed:citationSubsetIMlld:pubmed
pubmed-article:15701627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15701627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15701627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15701627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15701627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15701627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15701627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15701627pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15701627pubmed:statusMEDLINElld:pubmed
pubmed-article:15701627pubmed:monthAprlld:pubmed
pubmed-article:15701627pubmed:issn0021-9258lld:pubmed
pubmed-article:15701627pubmed:authorpubmed-author:WilsonSamuel...lld:pubmed
pubmed-article:15701627pubmed:authorpubmed-author:HortonJulie...lld:pubmed
pubmed-article:15701627pubmed:authorpubmed-author:KedarPadmini...lld:pubmed
pubmed-article:15701627pubmed:authorpubmed-author:NaronJana MJMlld:pubmed
pubmed-article:15701627pubmed:authorpubmed-author:StefanickDonn...lld:pubmed
pubmed-article:15701627pubmed:issnTypePrintlld:pubmed
pubmed-article:15701627pubmed:day22lld:pubmed
pubmed-article:15701627pubmed:volume280lld:pubmed
pubmed-article:15701627pubmed:ownerNLMlld:pubmed
pubmed-article:15701627pubmed:authorsCompleteYlld:pubmed
pubmed-article:15701627pubmed:pagination15773-85lld:pubmed
pubmed-article:15701627pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:meshHeadingpubmed-meshheading:15701627...lld:pubmed
pubmed-article:15701627pubmed:year2005lld:pubmed
pubmed-article:15701627pubmed:articleTitlePoly(ADP-ribose) polymerase activity prevents signaling pathways for cell cycle arrest after DNA methylating agent exposure.lld:pubmed
pubmed-article:15701627pubmed:affiliationLaboratory of Structural Biology, NIEHS, National Institutes of Health, Research Triangle Park, North Carolina 27709, USA.lld:pubmed
pubmed-article:15701627pubmed:publicationTypeJournal Articlelld:pubmed
entrez-gene:11545entrezgene:pubmedpubmed-article:15701627lld:entrezgene
entrez-gene:18970entrezgene:pubmedpubmed-article:15701627lld:entrezgene
entrez-gene:19645entrezgene:pubmedpubmed-article:15701627lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15701627lld:pubmed